Therakos, Inc., a Mallinckrodt Company
1 clinical trials · Sponsor
◉ Watch Therakos, Inc., a Mallinckrodt Company
| Record | Firm | Date |
|---|---|---|
| Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host Disease (NCT02524847) | Therakos, Inc., a Mallinckrodt Company | 2016-01-20 |
Track Therakos, Inc., a Mallinckrodt Company automatically
Every clearance here is in the API, with alerts when new ones post.